Found: 34
Select item for more details and to access through your institution.
Remdesivir is Associated with Reduced Mortality in Patients Hospitalized for COVID-19 Not Requiring Supplemental Oxygen.
- Published in:
- Open Forum Infectious Diseases, 2024, v. 11, n. 6, p. 1, doi. 10.1093/ofid/ofae202
- By:
- Publication type:
- Article
Remdesivir Is Associated With Reduced Mortality in COVID-19 Patients Requiring Supplemental Oxygen Including Invasive Mechanical Ventilation Across SARS-CoV-2 Variants.
- Published in:
- Open Forum Infectious Diseases, 2023, v. 10, n. 10, p. 1, doi. 10.1093/ofid/ofad482
- By:
- Publication type:
- Article
Clinical Management of Hospitalized Coronavirus Disease 2019 Patients in the United States.
- Published in:
- Open Forum Infectious Diseases, 2022, v. 9, n. 1, p. 1, doi. 10.1093/ofid/ofab498
- By:
- Publication type:
- Article
Remdesivir Versus Standard-of-Care for Severe Coronavirus Disease 2019 Infection: An Analysis of 28-Day Mortality.
- Published in:
- Open Forum Infectious Diseases, 2021, v. 8, n. 7, p. 1, doi. 10.1093/ofid/ofab278
- By:
- Publication type:
- Article
Remdesivir for Hospitalized COVID-19 Patients in the United States: Optimization of Health Care Resources.
- Published in:
- Infectious Diseases & Therapy, 2023, v. 12, n. 6, p. 1655, doi. 10.1007/s40121-023-00816-y
- By:
- Publication type:
- Article
Consistent Effects of Early Remdesivir on Symptoms and Disease Progression Across At-Risk Outpatient Subgroups: Treatment Effect Heterogeneity in PINETREE Study.
- Published in:
- Infectious Diseases & Therapy, 2023, v. 12, n. 4, p. 1189, doi. 10.1007/s40121-023-00789-y
- By:
- Publication type:
- Article
Monoclonal Antibodies in Hospitalised Patients with COVID-19: The Role of SARS-COV-2 Serostatus in an Evolving Pandemic.
- Published in:
- Infectious Diseases & Therapy, 2023, v. 12, n. 3, p. 735, doi. 10.1007/s40121-023-00769-2
- By:
- Publication type:
- Article
Endogenous Antibody Responses to SARS-CoV-2 in Patients With Mild or Moderate COVID-19 Who Received Bamlanivimab Alone or Bamlanivimab and Etesevimab Together.
- Published in:
- Frontiers in Immunology, 2021, v. 12, p. 1, doi. 10.3389/fimmu.2021.790469
- By:
- Publication type:
- Article
A Randomized Trial of Mesenchymal Stromal Cells for Moderate to Severe ARDS From COVID-19.
- Published in:
- American Journal of Respiratory & Critical Care Medicine, 2023, v. 207, n. 3, p. 261, doi. 10.1164/rccm.202201-0157OC
- By:
- Publication type:
- Article
Anti-Granulocyte–Macrophage Colony–Stimulating Factor Monoclonal Antibody Gimsilumab for COVID-19 Pneumonia: A Randomized, Double-Blind, Placebo-controlled Trial.
- Published in:
- American Journal of Respiratory & Critical Care Medicine, 2022, v. 205, n. 11, p. 1290, doi. 10.1164/rccm.202108-1859OC
- By:
- Publication type:
- Article
Responses to a Neutralizing Monoclonal Antibody for Hospitalized Patients With COVID-19 According to Baseline Antibody and Antigen Levels : A Randomized Controlled Trial.
- Published in:
- 2022
- By:
- Publication type:
- journal article
Association of Remdesivir Treatment With Mortality Among Hospitalized Adults With COVID-19 in the United States.
- Published in:
- JAMA Network Open, 2022, v. 5, n. 12, p. e2244505, doi. 10.1001/jamanetworkopen.2022.44505
- By:
- Publication type:
- Article
Associations of Mental Health and Experience of the COVID-19 Pandemic with United States Adults' Intentions to Be Vaccinated.
- Published in:
- Population Health Management, 2023, v. 26, n. 5, p. 317, doi. 10.1089/pop.2023.0136
- By:
- Publication type:
- Article
Tocilizumab and remdesivir in hospitalized patients with severe COVID-19 pneumonia: a randomized clinical trial.
- Published in:
- Intensive Care Medicine, 2021, v. 47, n. 11, p. 1258, doi. 10.1007/s00134-021-06507-x
- By:
- Publication type:
- Article
No Remdesivir Resistance Observed in the Phase 3 Severe and Moderate COVID-19 SIMPLE Trials.
- Published in:
- Viruses (1999-4915), 2024, v. 16, n. 4, p. 546, doi. 10.3390/v16040546
- By:
- Publication type:
- Article
Randomized, Placebo-Controlled Clinical Trial of Bamlanivimab and Etesevimab Together in High-Risk Ambulatory Patients With COVID-19 and Validation of the Prognostic Value of Persistently High Viral Load.
- Published in:
- Clinical Infectious Diseases, 2022, v. 75, n. 1, p. e440, doi. 10.1093/cid/ciab912
- By:
- Publication type:
- Article
Remdesivir Treatment in Hospitalized Patients With Coronavirus Disease 2019 (COVID-19): A Comparative Analysis of In-hospital All-cause Mortality in a Large Multicenter Observational Cohort.
- Published in:
- Clinical Infectious Diseases, 2022, v. 75, n. 1, p. e450, doi. 10.1093/cid/ciab875
- By:
- Publication type:
- Article
Olympiad of Severe Acute Respiratory Syndrome Coronavirus 2 Vaccinology: Fundamentals to Complement Technical Frontiers.
- Published in:
- Clinical Infectious Diseases, 2021, v. 73, n. 11, p. e3956, doi. 10.1093/cid/ciab088
- By:
- Publication type:
- Article
Remdesivir for Severe Coronavirus Disease 2019 (COVID-19) Versus a Cohort Receiving Standard of Care.
- Published in:
- Clinical Infectious Diseases, 2021, v. 73, n. 11, p. e4166, doi. 10.1093/cid/ciaa1041
- By:
- Publication type:
- Article
Racial/ethnic Disparities Not Observed in Clinical Outcomes with Remdesivir Treatment.
- Published in:
- Infection & Chemotherapy, 2020, v. 52, p. S382
- By:
- Publication type:
- Article
Association Between Concomitant Hydroxychloroquine Use and Safety and Efficacy of Remdesivir in Severe COVID-19 Patients.
- Published in:
- Infection & Chemotherapy, 2020, v. 52, p. S380
- By:
- Publication type:
- Article
Effect of Bamlanivimab as Monotherapy or in Combination With Etesevimab on Viral Load in Patients With Mild to Moderate COVID-19: A Randomized Clinical Trial.
- Published in:
- JAMA: Journal of the American Medical Association, 2021, v. 325, n. 7, p. 632, doi. 10.1001/jama.2021.0202
- By:
- Publication type:
- Article
Effect of Remdesivir vs Standard Care on Clinical Status at 11 Days in Patients With Moderate COVID-19: A Randomized Clinical Trial.
- Published in:
- 2020
- By:
- Publication type:
- journal article
True DisCoVeRy of COVID-19 Disease Burden Versus Speculated Antiviral Cardiovascular Risk Requires a Control Group.
- Published in:
- 2024
- By:
- Publication type:
- Editorial
Remdesivir Reduced Mortality in Immunocompromised Patients Hospitalized for COVID-19 Across Variant Waves: Findings From Routine Clinical Practice.
- Published in:
- Clinical Infectious Diseases, 2023, v. 77, n. 12, p. 1626, doi. 10.1093/cid/ciad460
- By:
- Publication type:
- Article
Consensus recommendations for use of maintenance immunosuppression in solid organ transplantation: Endorsed by the American College of Clinical Pharmacy, American Society of Transplantation, and International Society for Heart and Lung Transplantation: An executive summary
- Published in:
- Pharmacotherapy, 2022, v. 42, n. 8, p. 594, doi. 10.1002/phar.2718
- By:
- Publication type:
- Article
Consensus recommendations for use of maintenance immunosuppression in solid organ transplantation: Endorsed by the American College of Clinical Pharmacy, American Society of Transplantation, and the International Society for Heart and Lung Transplantation
- Published in:
- Pharmacotherapy, 2022, v. 42, n. 8, p. 599, doi. 10.1002/phar.2716
- By:
- Publication type:
- Article
REMDESIVIR IS ASSOCIATED WITH REDUCED READMISSION AFTER COVID-19 HOSPITALIZATION.
- Published in:
- Topics in Antiviral Medicine, 2023, v. 31, n. 2, p. 219
- By:
- Publication type:
- Article
REMDESIVIR REDUCES MORTALITY IN IMMUNOCOMPROMISED PATIENTS HOSPITALIZED FOR COVID-19.
- Published in:
- Topics in Antiviral Medicine, 2023, v. 31, n. 2, p. 219
- By:
- Publication type:
- Article
REMDESIVIR REDUCES MORTALITY IN HOSPITALIZED COVID-19 PATIENTS ACROSS VARIANT ERAS.
- Published in:
- Topics in Antiviral Medicine, 2023, v. 31, n. 2, p. 218
- By:
- Publication type:
- Article
Multi-center matched cohort study of convalescent plasma for hospitalized patients with COVID-19.
- Published in:
- PLoS ONE, 2022, v. 17, n. 8, p. 1, doi. 10.1371/journal.pone.0273223
- By:
- Publication type:
- Article
De novo tacrolimus extended‐release tablets (LCPT) versus twice‐daily tacrolimus in adult heart transplantation: Results of a single‐center non‐inferiority matched control trial.
- Published in:
- Clinical Transplantation, 2021, v. 35, n. 12, p. 1, doi. 10.1111/ctr.14487
- By:
- Publication type:
- Article
Outpatient COVID‐19 surveillance testing in orthotopic heart transplant recipients.
- Published in:
- Clinical Transplantation, 2020, v. 34, n. 12, p. 1, doi. 10.1111/ctr.14105
- By:
- Publication type:
- Article
Arrhythmogenic Right Ventricular Dysplasia: An Under-recognized Form of Inherited Cardiomyopathy.
- Published in:
- 2017
- By:
- Publication type:
- journal article